Study of insulin resistance in relation to serum IGF-I levels in subjects with different degrees of glucose tolerance
- PMID: 19902049
- PMCID: PMC2772007
- DOI: 10.4103/0973-3930.43100
Study of insulin resistance in relation to serum IGF-I levels in subjects with different degrees of glucose tolerance
Abstract
Aim: We studied the correlations between fasting and post-lunch serum IGF-I concentrations, and insulin resistance and insulin sensitivity in subjects with various degrees of glucose tolerance.
Materials and methods: A total of 12 nondiabetic subjects, 09 subjects with impaired glucose tolerance (IGT) and 18 patients with newly diagnosed type-2 diabetes of either sex (mean age, 46 years) were recruited. None of the participants received any drug treatment at the commencement of the study. Fasting as well as post-lunch blood samples were collected from all the subjects and anthropometric and biochemical parameters were analyzed.
Results: Fasting serum IGF-I concentrations were negatively correlated with fasting serum glucose, insulin, C-peptide, triglycerides, total LDL and VLDL cholesterol, homeostatic model assessment of insulin resistance (HOMA-IR), and age. Fasting serum IGF-I concentrations were positively correlated with fasting blood HDL cholesterol and homeostatic model assessment of insulin sensitivity (HOMA-S) in only diabetic subjects. Post-lunch serum IGF-I concentrations were positively correlated with HDL and LDL cholesterol. Correlations with HOMA-S with these metabolic anthropometric variables were of similar magnitude and direction as that of IGF-I concentrations. IGF-I concentrations were significantly lower in the subjects with World Health Organization-defined metabolic syndrome compared with the subjects without metabolic syndrome (P < 0.0001).
Conclusions: Our data indicate that IGF-I could be a useful marker in the insulin resistance syndrome. The post-lunch low-IGF-I levels help in better identification of subjects at risk for type-2 diabetes mellitus and cardiovascular disease.
Keywords: Diabetes mellitus; insulin like growth factor-I (IGF-I); insulin resistance syndrome.
Conflict of interest statement
Similar articles
-
Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance.Diabetes Care. 2005 Jan;28(1):120-5. doi: 10.2337/diacare.28.1.120. Diabetes Care. 2005. PMID: 15616244
-
Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.Ethn Dis. 2002 Fall;12(4):S3-10-7. Ethn Dis. 2002. PMID: 12477148
-
Expression of C1q/TNF-related protein-3 (CTRP3) in serum of patients with gestational diabetes mellitus and its relationship with insulin resistance.Eur Rev Med Pharmacol Sci. 2017 Dec;21(24):5702-5710. doi: 10.26355/eurrev_201712_14016. Eur Rev Med Pharmacol Sci. 2017. PMID: 29272006
-
Low insulin-like growth factor 1 is associated with low high-density lipoprotein cholesterol and metabolic syndrome in Chinese nondiabetic obese children and adolescents: a cross-sectional study.Lipids Health Dis. 2016 Jun 24;15:112. doi: 10.1186/s12944-016-0275-7. Lipids Health Dis. 2016. PMID: 27343122 Free PMC article.
-
Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.Dan Med Bull. 2002 Feb;49(1):43-60. Dan Med Bull. 2002. PMID: 11894723 Review.
Cited by
-
Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes.Endocrinol Metab Clin North Am. 2012 Jun;41(2):425-43, vii-viii. doi: 10.1016/j.ecl.2012.04.017. Endocrinol Metab Clin North Am. 2012. PMID: 22682639 Free PMC article. Review.
-
Insulin-like growth factor-1 deficiency and metabolic syndrome.J Transl Med. 2016 Jan 6;14:3. doi: 10.1186/s12967-015-0762-z. J Transl Med. 2016. PMID: 26733412 Free PMC article. Review.
References
-
- Reaven GM. Banting lecture 1988: Role of insulin resistance in human disease. Diabetes. 1988;37:1595–607. - PubMed
-
- Yakar S, Liu JL, Fernandez AM, Wu Y, Schally AV, Frystyk J, et al. Liver-specific IGF-1gene deletion leads to muscle insulin insensitivity. Diabetes. 2001;50:1110–18. - PubMed
-
- Sjogren K, Wallenius K, Liu JL, Bohlooly- YM, Pacini G, Svensson L, et al. Liver-derived IGF-I is of importancefor normal carbohydrate andlipid metabolism. Diabetes. 2001;50:1539–45. - PubMed
-
- Moses AC, Young SC, Morrow LA, O'Brien M, Clemmons DR. Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes. Diabetes. 1996;45:91–100. - PubMed
LinkOut - more resources
Full Text Sources